Last edition
News about "CHMP"
AbbVie Gets Positive CHMP Opinion for Mirvetuximab Soravtansine
AbbVie has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of mirvetuximab soravtansine (ELAHERE).
CHMP | 21/09/2024 | By Aishwarya | 114
Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars
CHMP | 26/06/2023 | By Sudeep Soparkar | 449
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy